Novavax Inc's COVID-19 vaccine NVX-CoV2373 demonstrated 90.4% overall efficacy against SARS-CoV-2 infection, and 100% protection against moderate and severe disease, according to a Phase 3 PREVENT-19 clinical trial.
Genetic evidence does not support vitamin D as a protective measure against COVID-19, and studies suggesting protective benefits are inconclusive and possibly subject to confounding.
A chemotherapy drug Topotecan, which targets inflammatory genes, reduced morbidity and mortality in mice infected with SARS-CoV-2.
A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health
Read More
Fully vaccinated adults 65 years and older were 94% less likely to be hospitalized with COVID-19, and partially vaccinated adults 65+ were 64% less likely to be hospitalized.
Read More
Substantial proportions of pregnant and postpartum women scored high for symptoms of anxiety, depression, loneliness and post-traumatic stress in relation to COVID-19.
Read More
NIH will conduct a clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia.
Read MoreAccording to data from the CDC, 8% of people who have received a first dose of the Pfizer or Moderna vaccines have missed their second scheduled dose.
Read More
New research published in Journal of Oral Medicine and Dental Research found that gum disease, along with high concentrations of SARS-CoV-2 in saliva, increased mortality risk for COVID-19 patients.
Read More
The CDC has issued new guidance for mask wearing that says fully vaccinated Americans no longer need to wear masks in outdoor settings, unless it is a large gathering of non-household members.
Read More
A Phase 3 clinical trial will explore a pool of up to seven drugs approved by FDA for other conditions – an approach called drug repurposing – and test their safety and effectiveness in treating mild to moderate COVID-19.
Read More
The CDC says the risk of COVID-19 transmission via surfaces is low and frequent disinfection practices using common household chemicals pose a danger and may amount to “hygiene theater.”
Read More
The Biden Administration says it will create a national network to identify and track viral mutations of coronavirus in order to prevent future pandemics, according to the AP. The network will cost approximately $1.7 billion to create.
Read More
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
Read More
The US FDA has revoked an EUA for the monoclonal antibody bamlanivimab when administered alone, for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
Read More